Abnormal Mitochondrial Trafficking and Cytoskeletal Organization in a Human Induced Pluripotent Stem Cell and a Mouse Model of Charcot-Marie-Tooth Disease Type 2E

被引：0
|
作者：
Saporta, Mario [1 ]
Volfson, Dmitri [2 ]
Adebola, Adijat [3 ]
Shy, Michael [4 ]
Liem, Ronald [3 ]
Dimos, John [2 ]
机构：
[1] Wayne State Univ, San Francisco, CA USA
[2] iPierian Inc, San Francisco, CA USA
[3] Columbia Univ, Coll Phys & Surg, New York, NY USA
[4] Wayne State Univ, Detroit, MI USA
来源：
NEUROLOGY | 2012年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S27002
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Charcot-Marie-Tooth disease Type 2E/1F mutant neurofilament proteins assemble into neurofilaments
    Stone, Elizabeth J.
    Uchida, Atsuko
    Brown, Anthony
    CYTOSKELETON, 2019, 76 (7-8) : 423 - 439
  • [22] Muscle spindle alterations precede onset of sensorimotor deficits in Charcot-Marie-Tooth type 2E
    Villalon, E.
    Jones, M. R.
    Sibigtroth, C.
    Zino, S. J.
    Dale, J. M.
    Landayan, D. S.
    Shen, H.
    Cornelison, D. D. W.
    Garcia, M. L.
    GENES BRAIN AND BEHAVIOR, 2017, 16 (02) : 260 - 270
  • [23] Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E
    De Jonghe, P
    Mersivanova, I
    Nelis, E
    del Favero, J
    Martin, JJ
    Van Broeckhoven, C
    Evgrafov, OC
    Timmerman, V
    ANNALS OF NEUROLOGY, 2001, 49 (02) : 245 - 249
  • [24] Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA
    Huxley, C
    Passage, E
    Manson, A
    Putzu, G
    FigarellaBranger, D
    Pellissier, JF
    Fontes, M
    HUMAN MOLECULAR GENETICS, 1996, 5 (05) : 563 - 569
  • [25] Neuromuscular Junction Changes in a Mouse Model of Charcot-Marie-Tooth Disease Type 4C
    Cipriani, Silvia
    Phan, Vietxuan
    Medard, Jean-Jacques
    Horvath, Rita
    Lochmueller, Hanns
    Chrast, Roman
    Roos, Andreas
    Spendiff, Sally
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (12)
  • [26] UTILIZING KINASE INHIBITORS TO AMELIORATE NEUROFILAMENT AGGREGATION IN AN IPSC-DERIVED MOTOR NEURON MODEL OF CHARCOT-MARIE-TOOTH DISEASE TYPE 2E
    Jacobs, Elizabeth
    Medina, Jessica
    Zuchner, Stephan
    Saporta, Mario
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2022, 27 : S58 - S59
  • [27] Preclinical gene therapy in a mouse model of Charcot-Marie-Tooth disease type 4J
    Lutz, Cathleen
    Presa, Maxmiliano
    Davis, Crystal
    Cook, Jennifer
    Murphy, Tara
    Burgess, Rob
    Bailey, Rachel M.
    Gray, Steven J.
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S96 - S97
  • [28] Expression profiling of sciatic nerve in a Charcot-Marie-Tooth disease type 1a mouse model
    ten Asbroek, ALMA
    Verhamme, C
    van Groenigen, M
    Wolterman, R
    de Kok-Nazaruk, MM
    Baas, F
    JOURNAL OF NEUROSCIENCE RESEARCH, 2005, 79 (06) : 825 - 835
  • [29] Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A
    Franco, Antonietta
    Dang, Xiawei
    Zhang, Lihong
    Molinoff, Perry B.
    Dorn, Gerald W., II
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2022, 383 (02): : 137 - 148
  • [30] Establishing a human-induced pluripotent stem cell line (SMUSHi003-A) from a patient with Charcot-Marie-Tooth disease and focal segmental glomerulosclerosis
    Lei, Qunjuan
    Zhou, Wenyan
    Huang, Ling
    Zhang, Yu
    Xu, Xueqing
    Guo, Xiaohua
    STEM CELL RESEARCH, 2024, 76
12345